Comment on “Conjunctival microbiota in retinal diseases requiring anti-VEGF therapy: Age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion”
- 24 April 2026
- journal article
- Published by SAGE Publications in European Journal of Ophthalmology
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Conjunctival Microbiota in retinal diseases requiring anti-VEGF therapy: Age-related macular degeneration, diabetic retinopathy, and retinal vein occlusionEuropean Journal of Ophthalmology, 2025
- The human microbiome in clinical translation: from bench to bedsideFrontiers in Microbiology, 2025
- Distinct cytokine profiles in plasma and tears highlight ophthalmologic inflammation in type 2 diabetes without retinopathyFrontiers in Medicine, 2025
- Unraveling the immune–microbial axis in chronic ocular surface diseaseCurrent Opinion in Allergy and Clinical Immunology, 2025